Cryptococcus albidus meningitis: A case report and literature review
Genzhu Wang1, Hang Liu, Xiaoying Wang
1Beijing Electric Power Hospital of State Grid Co. of China, Capital Medical University Electric Teaching Hospital, Beijing, China.
Rationale:
Central nervous system (CNS) infections caused by Cryptococcus albidus are rarely reported, but are often associated with high mortality rates. Clinical data on the appropriate use of liposomal-amphotericin B (liposomal-AmB) with cryptococcal meningitis are limited. Here, we report for the first time the efficacious and safe use of the ideal bodyweight to calculate the dose of liposomal-AmB for a severely obese patient with C albidus meningitis. We also review the cases of CNS infection caused by C albidus and its related species.
Patient Concerns:
A severely obese female patient was admitted to neurosurgical ward with lesions in the intracranial space and accompanying headache. Brain magnetic resonance imaging revealed prominent lesions in the right parietal and left frontal insular region. After glioma resection, C albidus was isolated from her cerebrospinal fluid samples.
Diagnoses, Interventions, And Outcomes:
She diagnosed histopathologically with a Cryptococcus species infection. The culture from her cerebrospinal fluid sample showed the growth of yeast-like colonies, which were identified as C albidus with mass spectrometry. She was treated with liposomal-AmB (50 mg day-1 intravenously) plus 5-fluorocytosine (10 g day-1 orally in 4 divided doses) for 6 weeks. The patient was asymptomatic at the time of discharge.
Lessons:
CNS infections of C albidus were uncommon. Using ideal bodyweight to calculate the dose of liposomal-AmB should be considered for severely obese patients with C albidus meningitis.
Insights
Central nervous system infections from Cryptococcus albidus are rare but dangerous. This study highlights using ideal body weight for liposomal-amphotericin B dosing in obese patients with C. albidus meningitis, ensuring safe and effective treatment.
Area of Science:
- Neuroscience
- Infectious Diseases
- Pharmacology
Background:
- Central nervous system (CNS) infections caused by Cryptococcus albidus are rare and associated with high mortality.
- Limited clinical data exists on the optimal use of liposomal-amphotericin B (liposomal-AmB) for cryptococcal meningitis.
Purpose of the Study:
- To report the first case of successful liposomal-AmB treatment for C. albidus meningitis in a severely obese patient.
- To evaluate the efficacy and safety of using ideal body weight for liposomal-AmB dosing in this patient population.
- To review existing literature on CNS infections caused by C. albidus and related species.
Main Methods:
- A severely obese female patient presented with intracranial lesions and headache.
- C. albidus was isolated from cerebrospinal fluid after glioma resection.
- Treatment involved liposomal-AmB (50 mg/day IV) and 5-fluorocytosine (10 g/day PO) for 6 weeks.
Main Results:
- The patient's Cryptococcus species infection was confirmed via cerebrospinal fluid culture and mass spectrometry.
- The patient received liposomal-AmB and 5-fluorocytosine for 6 weeks.
- The patient was asymptomatic upon discharge, indicating successful treatment.
Conclusions:
- CNS infections due to C. albidus are uncommon.
- Calculating liposomal-AmB dosage based on ideal body weight is a recommended approach for severely obese patients with C. albidus meningitis.
Related Concept Videos
Bacterial Meningitis
Viral Meningitis
Cryptococcal Meningitis
Bacterial Meningitis I: Introduction
Bacterial Meningitis II: Pathophysiology
Brain Abscess l: Introduction


